About Ovarian Cancer

Over 90% of ovarian cancer arises from the uncontrolled growth and replication of epithelial cells which form the surface of the ovary...
Read More ››

About Clinical Trials

Clinical trials are scientific studies that determine whether an investigational drug is safe and effective to treat a disease...
Read More ››

About Rucaparib

Rucaparib is an investigational drug that comes in tablets, can be taken by mouth, and is being tested in ovarian cancer...
Read More ››

ARIEL2 Clinical Trial

ARIEL2 (NCT#01891344) is a Phase 2 trial for women with relapsed, high-grade serous or endometrioid ovarian cancer...
Read More ››

ARIEL3 Clinical Trial

ARIEL3 (NCT# 01968213) is a Phase 3 trial designed to evaluate the effect of rucaparib as maintenance treatment...
Read More ››

How to Participate

To find a clinical trial site in the United States, view our interactive trial site map, which is updated periodically with site locations...
Read More ››

The information contained in this session of the site is intended for heathcare professionals only. Select "OK" if you are a US professional.

The information contained in this session of the site is intended for heathcare professionals only. Select "OK" if you are a US professional.